Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Public health decisions should rely on independent trials, not biased literature.

A topical solution with minoxidil and rosemary oil may help treat hair loss.

A combined medical and aesthetic approach is crucial for effectively managing PCOS and its skin-related issues.

Home photobiomodulation therapy can improve life quality and mobility for disabled individuals.

Platelet-rich plasma helps treat post-COVID-19 hair loss and boosts self-esteem.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Alopecia areata may be caused by the immune system attacking hair follicles.

IL-18 signaling helps mature Tregs move into the thymus.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Six months after COVID-19, most patients still had autoantibodies.